Rubric Capital Management (New York)’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-491,322
Closed -$16.6M 69
2023
Q4
$16.6M Buy
491,322
+31,685
+7% +$1.07M 0.34% 41
2023
Q3
$14.1M Buy
+459,637
New +$14.1M 0.53% 42